Concert Pharmaceuticals

FDA stop sign
Biotech

Sun's $576M Concert hits bum note as FDA imposes partial hold

Two months after closing the deal, Sun has revealed a blood clot has triggered a partial FDA hold on development of Concert’s key candidate.
Nick Paul Taylor May 2, 2023 7:09am
FDA

Concert persuades FDA to keep alopecia therapy breakthrough tag

Feb 15, 2023 10:00am
Illustration connected puzzle pieces with the acronym MA

Concert joins Sun Pharma's symphony in $576M acquisition

Jan 19, 2023 11:30am
picture of a paraglider

Agios replaces CEO after recent FDA nod—Chutes & Ladders

Jul 15, 2022 9:30am
Financial data on a stock ticker

Chasing Lilly, Concert alopecia drug hits high notes in phase 3

May 23, 2022 9:05am
Pill bottle with pills shaped into question mark

Concert tunes pipeline by selling off CNS assets to startup

Mar 11, 2022 12:30pm